Literature DB >> 31821043

Association of Diastolic Dysfunction with Reduced Cardiorespiratory Fitness in Adults Living with HIV.

Krisann K Oursler1,2, Hillary M O'Boyle1, Brandon C Briggs2, John D Sorkin3,4, Nabil Jarmukli2, Leslie I Katzel3,4, Matthew S Freiberg5, Alice S Ryan3,4.   

Abstract

Despite the high prevalence of diastolic dysfunction in adults living with HIV, the impact on cardiorespiratory fitness (CRF) is understudied. The objective of this cross-sectional study was to investigate the relationship between cardiac function and CRF in adults with HIV. Adults receiving antiretroviral therapy with no history of coronary artery disease (CAD) or heart failure were eligible to participate. Cardiac function was assessed by resting Doppler echocardiography. CRF was measured by oxygen utilization at peak exercise (VO2peak). The majority of participants were African American (86%) and male (97%) with a mean [standard deviation (SD)] age of 56.6 (7.1) years and median CD4 lymphocyte count of 492 cells/mL. The mean (SD) VO2peak was 26.1 (5.5) mL/(kg·min). Age, diabetes, hypertension, and hemoglobin were associated with VO2peak. Overall, diastolic dysfunction was present in 38% and was associated with lower VO2peak (p < 0.05). VO2peak was lower among those with impaired myocardial relaxation (e' <8 cm/s) compared with normal relaxation [mean ± SE mL/(kg·min), 25.2 ± 0.6 vs. 27.7 ± 0.9, p < 0.05]. Adjusted for age and clinical factors, each unit increase in left ventricular relaxation (E/A) was associated with an average 4.4 mL/(kg·min) higher VO2peak, representing more than one metabolic equivalent. We conclude that diastolic dysfunction is independently associated with clinically significant low CRF in adults with HIV and no history of CAD or heart failure. These results highlight the importance of recognizing diastolic dysfunction in individuals living with HIV regardless of their cardiovascular disease history.

Entities:  

Keywords:  HIV; aerobic capacity; cardiorespiratory fitness; diastolic dysfunction; heart failure

Year:  2019        PMID: 31821043      PMCID: PMC6918848          DOI: 10.1089/apc.2019.0149

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  46 in total

1.  Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers.

Authors:  Udo Hoffmann; Michael T Lu; Devvora Olalere; Elizabeth C Adami; Michael T Osborne; Alex Ivanov; John Sukumar Aluru; Saeyun Lee; Nadja Arifovic; Edgar Turner Overton; Carl J Fichtenbaum; Judith A Aberg; Beverly Alston-Smith; Karin L Klingman; Myron Waclawiw; Tricia H Burdo; Kenneth C Williams; Markella V Zanni; Patrice Desvigne-Nickens; Katharine Cooper-Arnold; Kathleen V Fitch; Heather Ribaudo; Pamela S Douglas; Steven K Grinspoon
Journal:  Am Heart J       Date:  2019-03-04       Impact factor: 4.749

Review 2.  Definitions and diagnosis of pulmonary hypertension.

Authors:  Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

3.  Cardiopulmonary exercise testing variables reflect the degree of diastolic dysfunction in patients with heart failure-normal ejection fraction.

Authors:  Marco Guazzi; Jonathan Myers; Mary Ann Peberdy; Daniel Bensimhon; Paul Chase; Ross Arena
Journal:  J Cardiopulm Rehabil Prev       Date:  2010 May-Jun       Impact factor: 2.081

4.  Reduced aerobic capacity and physical functioning in older HIV-infected men.

Authors:  K K Oursler; J D Sorkin; B A Smith; L I Katzel
Journal:  AIDS Res Hum Retroviruses       Date:  2006-11       Impact factor: 2.205

5.  Abnormal Myocardial Function Is Related to Myocardial Steatosis and Diffuse Myocardial Fibrosis in HIV-Infected Adults.

Authors:  Diana K Thiara; Chia Ying Liu; Fabio Raman; Sabrina Mangat; Julia B Purdy; Horacio A Duarte; Nancyanne Schmidt; Jamie Hur; Christopher T Sibley; David A Bluemke; Colleen Hadigan
Journal:  J Infect Dis       Date:  2015-05-11       Impact factor: 5.226

Review 6.  Therapy for heart failure with preserved ejection fraction: current status, unique challenges, and future directions.

Authors:  Bharathi Upadhya; Mark J Haykowsky; Dalane W Kitzman
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

Review 7.  Exercise physiology in heart failure and preserved ejection fraction.

Authors:  Mark J Haykowsky; Dalane W Kitzman
Journal:  Heart Fail Clin       Date:  2014-05-22       Impact factor: 3.179

Review 8.  Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure.

Authors:  M Packer
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

9.  Silent cardiac dysfunction and exercise intolerance in HIV+ men receiving combined antiretroviral therapies.

Authors:  Gilles J Thöni; Iris Schuster; Guillaume Walther; Stéphane Nottin; Agnès Vinet; Franck Boccara; Jean-Marc Mauboussin; Isabelle Rouanet; Stéphane Edérhy; Michel Dauzat; Patick Messner-Pellenc; Philippe Obert
Journal:  AIDS       Date:  2008-11-30       Impact factor: 4.177

Review 10.  HIV-associated cardiovascular disease: importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies.

Authors:  Jeffrey Laurence; Sonia Elhadad; Jasimuddin Ahamed
Journal:  Open Heart       Date:  2018-07-11
View more
  2 in total

1.  Subclinical Left Ventricular Systolic Dysfunction in HIV Patients: Prevalence and Associations with Carotid Atherosclerosis and Increased Adiposity.

Authors:  Eleni Athanasiadi; Maria Bonou; Dimitrios Basoulis; Chris J Kapelios; Constantina Masoura; Marina Skouloudi; Sophie Mavrogeni; Constantina Aggeli; Mina Psichogiou; John Barbetseas
Journal:  J Clin Med       Date:  2022-03-24       Impact factor: 4.241

2.  Diagnosis and Management of HIV-Associated Pulmonary Diseases in a Ryan White-Funded Primary Care Setting.

Authors:  Kristin R V Harrington; Bashar S Staitieh; Minh Ly T Nguyen; Jonathan A Colasanti; Jieri Sumitani; Vincent C Marconi; Sara C Auld
Journal:  AIDS Patient Care STDS       Date:  2021-07       Impact factor: 5.944

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.